Friday, November 22, 2024
HomeTagsHCPCS

HCPCS

IDACIO® (adalimumab-aacf) Now Available in the United States

Fresenius Kabi announced the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics